Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 14 of 14  Show
  1. 1
    Category: Sequences.
    Strain: C57BL/6J.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 41322 other entries.

  2. 2
    "The transcriptional landscape of the mammalian genome."
    Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.
    Hayashizaki Y.
    Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 432-570.
    Category: Sequences.
    Strain: C57BL/6J.
    Tissue: Eye.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 10607 and mapped to 42736 other entries.

  3. 3
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250; SER-438 AND SER-440, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: PTM / Processing, Sequences.
    Tissue: Liver.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 3181 other entries.

  4. 4
    "The phagosomal proteome in interferon-gamma-activated macrophages."
    Trost M., English L., Lemieux S., Courcelles M., Desjardins M., Thibault P.
    Immunity 30:143-154(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-226 AND SER-343, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: PTM / Processing, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2003 and mapped to 129 other entries.

  5. 5
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-250; SER-343; SER-389; SER-406 AND SER-440, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: PTM / Processing, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 25174 other entries.

  6. 6
    "Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs."
    Okazaki Y., Furuno M., Kasukawa T., Adachi J., Bono H., Kondo S., Nikaido I., Osato N., Saito R., Suzuki H., Yamanaka I., Kiyosawa H., Yagi K., Tomaru Y., Hasegawa Y., Nogami A., Schonbach C., Gojobori T.
    Hayashizaki Y.
    Nature 420:563-573(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Sequences.
    Source: MGI:2443921.

    This publication is cited by 17022 and mapped to 40059 other entries.

  7. 7
    "Large-scale gene trapping in C57BL/6N mouse embryonic stem cells."
    Hansen G.M., Markesich D.C., Burnett M.B., Zhu Q., Dionne K.M., Richter L.J., Finnell R.H., Sands A.T., Zambrowicz B.P., Abuin A.
    Genome Res. 18:1670-1679(2008) [PubMed] [Europe PMC] [Abstract]
    Category: Sequences.
    Source: MGI:2443921.

    This publication is mapped to 29113 other entries.

  8. 8
    "IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression."
    Teng A.C., Kuraitis D., Deeke S.A., Ahmadi A., Dugan S.G., Cheng B.L., Crowson M.G., Burgon P.G., Suuronen E.J., Chen H.H., Stewart A.F.
    FASEB J. 24:4825-4834(2010) [PubMed] [Europe PMC] [Abstract]
    Annotation: IRF2BP2 is a novel ischemia-induced coactivator of VEGFA expression that may contribute to revascularization of ischemic cardiac and skeletal muscles.Imported.
    Source: MGI:2443921, GeneRIF:270110.

    This publication is cited by 1 and mapped to 34 other entries.

  9. 9
    "Quantitative proteomics of the integrin adhesome show a myosin II-dependent recruitment of LIM domain proteins."
    Schiller H.B., Friedel C.C., Boulegue C., Fassler R.
    EMBO Rep. 12:259-266(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:E9Q1P8.

    This publication is mapped to 301 other entries.

  10. 10
    "IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis."
    Chen H.H., Keyhanian K., Zhou X., Vilmundarson R.O., Almontashiri N.A., Cruz S.A., Pandey N.R., Lerma Yap N., Ho T., Stewart C.A., Huang H., Hari A., Geoffrion M., McPherson R., Rayner K.J., Stewart A.F.
    Circ. Res. 117:671-683(2015) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Annotation: Ablation of IRF2BP2 in macrophages worsens atherosclerosis in mice.Imported.
    Source: MGI:2443921, GeneRIF:270110.

    This publication is mapped to 4 other entries.

  11. 11
    "Control of developmentally primed erythroid genes by combinatorial co-repressor actions."
    Stadhouders R., Cico A., Stephen T., Thongjuea S., Kolovos P., Baymaz H.I., Yu X., Demmers J., Bezstarosti K., Maas A., Barroca V., Kockx C., Ozgur Z., van Ijcken W., Arcangeli M.L., Andrieu-Soler C., Lenhard B., Grosveld F., Soler E.
    Nat Commun 6:8893-8893(2015) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: MGI:2443921.

    This publication is mapped to 7 other entries.

  12. 12
    "IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering."
    Secca C., Faget D.V., Hanschke S.C., Carneiro M.S., Bonamino M.H., de-Araujo-Souza P.S., Viola J.P.
    J. Leukoc. Biol. 100:1081-1091(2016) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Irf2bp2 gene expression was decreased in CD4 T cells upon activation. Ectopic expression of IRF2BP2 led to a reduction in CD25 expression and STAT5 phosphorylation along with an impaired proliferative capacity. IRF2BP2 overexpression in differentiated Th cells resulted in reduced IL-4 and pro-TGF-beta production in Th2 and iTregs but had no effect on IFN-gamma or IL-17 expression in Th1 and Th17 cells respectively.Imported.
    Source: GeneRIF:270110.
  13. 13
    "Control of Pathological Cardiac Hypertrophy by Transcriptional Corepressor IRF2BP2 (Interferon Regulatory Factor-2 Binding Protein 2)."
    Fang J., Li T., Zhu X., Deng K.Q., Ji Y.X., Fang C., Zhang X.J., Guo J.H., Zhang P., Li H., Wei X.
    Hypertension 70:515-523(2017) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: IRF2BP2 as a novel negative regulator in controlling pathological Cardiac Hypertrophy at the transcriptional level was defined.Imported.
    Source: GeneRIF:270110.
  14. 14
    "IRF2BP2-deficient microglia block the anxiolytic effect of enhanced postnatal care."
    Hari A., Cruz S.A., Qin Z., Couture P., Vilmundarson R.O., Huang H., Stewart A.F.R., Chen H.H.
    Sci Rep 7:9836-9836(2017) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Pathology & Biotech.
    Source: MGI:2443921.

    This publication is mapped to 3 other entries.

1 to 14 of 14  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again